A peptide vial label can tell you what was ordered. A certificate of analysis, or COA, is where you check whether the supplied material has documentation to support that label. Knowing how to read peptide COA paperwork helps researchers compare suppliers, verify lot-specific testing, and avoid relying on broad purity claims without context.
A useful COA is clear, traceable, and tied to the exact lot in hand. It should make it easy to answer a few practical questions: Was this specific batch tested? Does the result match the stated compound? Which analytical method was used? What does the purity figure actually represent?
Start With the Lot Number
The first check is also the fastest: match the COA lot number to the lot number on the vial, package, or order documentation. If the numbers do not match, the report may belong to a different production batch. That does not automatically prove a problem, but it does mean the report cannot verify the material you received.
Look for a batch or lot identifier near the top of the certificate. It may appear as “Lot No.,” “Batch No.,” or a similar label. The same document should also identify the compound name, often alongside the submitted sample name and the date of analysis.
Lot-specific documentation matters because separate production runs can differ. A generic sample report may show that a supplier has tested a compound at some point. A report connected to your actual lot provides much stronger quality visibility.
How to Read Peptide COA Identity Results
A COA should include an identity check, most commonly performed with LC-MS or mass spectrometry. This test measures molecular mass and compares the observed result with the expected molecular weight for the peptide.
You may see fields such as “Calculated Mass,” “Expected Mass,” “Observed Mass,” “Molecular Weight,” or “MS Result.” The observed mass should closely align with the expected value. Small differences can occur depending on how a result is displayed, including charge states, salt forms, or instrument reporting conventions. The report should still indicate that the identity result passed or conforms to specification.
For example, a peptide report may list an expected molecular weight of 1419.5 and show an observed mass that corresponds appropriately to that molecule. The exact presentation varies by lab, so do not assume every report will use the same layout. What matters is a clear connection between the expected compound and the measured result.
Mass spectrometry supports identity confirmation, but it does not replace purity analysis. A sample can show the expected target mass while still containing other material. That is why a credible COA typically includes both identity and purity information.
Understand the Purity Figure in Context
Many buyers go straight to the purity percentage. It is a valuable number, but it should never be read in isolation. A reported purity of 99% generally means the target peak represents approximately 99% of the measured chromatographic area under the stated test conditions. It does not mean every possible contaminant has been tested by every possible method.
For peptides, purity is commonly measured using HPLC or UPLC. The chromatogram separates components in the sample over time, creating peaks. The primary peak is normally associated with the target peptide, while smaller peaks may represent related compounds, synthesis byproducts, degradation products, or other detectable components.
A COA may list the result as “Purity: 99.2%,” “HPLC Area %,” or “Assay by HPLC.” Read the method note near that figure. If the certificate does not identify the method, wavelength, or basic analytical conditions, the result provides less context than a full report.
High purity is a meaningful quality marker, but the right threshold depends on the research requirement and the material being evaluated. A buyer comparing suppliers should prioritize transparent, lot-specific records over unsupported claims of perfect purity. A round “100%” figure with no chromatogram, method, or lab details deserves more scrutiny than a detailed 99-plus-percent result backed by supporting data.
Read the Chromatogram, Not Just the Number
The HPLC chromatogram is often the most useful visual section of a peptide COA. It shows retention time along the horizontal axis and detector response on the vertical axis. The major peak should be prominent and should align with the reported purity calculation.
A few small secondary peaks are not unusual in analytical data. The question is whether the report explains the main peak clearly and whether the stated purity makes sense compared with what is shown. A clean chromatogram with a dominant primary peak and limited minor peaks supports the reported result.
Also check whether the chromatogram has labels, a sample ID, an acquisition date, and a method reference. A chart without identifying information may be difficult to tie to a specific lot.
Check the Testing Method and Lab Details
A reliable COA identifies how the sample was analyzed. At minimum, look for the analytical method used for purity and identity. HPLC or UPLC is commonly used for purity profiling, while LC-MS or MS is commonly used to support identity verification.
The report should also include the testing laboratory name or source, report date, sample identifier, and an authorized signature, analyst name, or quality-control approval. Formatting differs from one lab to another, but traceability should be easy to follow.
Third-party testing can add useful separation between the seller and the analyst. Still, third-party status alone is not a guarantee. Review whether the documentation is complete, lot-specific, and internally consistent. A recognizable lab name does not help much if the certificate lacks a batch number, method details, or readable results.
Some COAs include additional testing such as water content, peptide content, residual solvent screening, endotoxin screening, or microbial analysis. Whether these results are relevant depends on the research workflow and the product format. Lyophilized material, for example, may be accompanied by different supporting data than a liquid preparation.
Do not expect every COA to contain every test. Instead, evaluate whether the available documentation matches the supplier’s claims and the level of verification appropriate for your intended research use.
Watch for These COA Red Flags
A questionable report is often easy to spot when you know what should be present. Be cautious when a COA has no lot number, uses a vague compound name, shows an unreadable chromatogram, or does not identify the analytical method.
Other warning signs include conflicting dates, purity claims without supporting data, identity results that do not align with the stated peptide, and documents reused across unrelated products. A certificate that looks heavily edited, contains obvious spelling errors in key fields, or provides no accountable testing source should also prompt questions.
One issue alone is not always decisive. Labs use different templates, and documents can be concise. But several missing pieces together reduce confidence. If a supplier cannot provide clear, current analysis for a listed research compound, there is little basis for treating a purity claim as verified.
Compare COAs Across Suppliers Carefully
COAs are not standardized across the entire peptide market. Comparing one supplier’s 99% HPLC result to another’s 99% claim is not always an apples-to-apples comparison. The test conditions, detector wavelength, reporting format, and lot traceability can vary.
Use the same evaluation sequence each time: confirm the lot, verify identity, review purity and the chromatogram, inspect the stated methods, then check lab and report details. This keeps the comparison grounded in documentation rather than marketing language.
At Biotech Labz Supply, visible lab analysis is part of the quality-first approach because informed buyers should be able to review the information behind the product listing. For repeat orders, save the lot number and COA with your research records. It makes later comparisons faster and helps maintain consistent documentation across purchases.
A COA should reduce uncertainty, not create it. When the lot matches, the identity result is clear, the chromatogram supports the purity claim, and the testing details are traceable, you have a stronger foundation for selecting research supplies with confidence.
